Due to the impact of E2F1 on GRNs in cancer cells and the observed intriguing changes in IL-6 secretion, we wondered to what extent gene expression profiles of melanoma and T cells are altered, and whether E2F1-KD can positively influence the genomic program of T cells in the sense of an antitumor immune response. The gene discussed is E2F1; the disease is cancer.